Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple Negative Breast Cancer Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04750382
What this trial is testing

HX008 for the Treatment of Patients With Metastatic Triple Negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Taizhou Hanzhong biomedical co. LTD 31
Not applicableStudy completedNCT02266420
What this trial is testing

Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm

Who this might be right for
Triple Negative Breast Cancers Without Lymph-node Involvement and < or = 30 mm
Institut Claudius Regaud 151
Not applicableActive Not RecruitingNCT06833723
What this trial is testing

Development of a Multi-omics Prediction Model for Immunotherapy Response in Triple-Negative Breast Cancer Subtypes

Who this might be right for
Breast Neoplasms
Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences 1,000
Early research (Phase 1)Ended earlyNCT02365662
What this trial is testing

A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor

Who this might be right for
Head and Neck Squamous Cell CarcinomaNon-small Cell Lung CancerTriple Negative Breast Cancer+2 more
AbbVie 46
Post-approval studies (Phase 4)Ended earlyNCT02688803
What this trial is testing

Multicentre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Three Standard of Care Regimens for The Treatment of Triple-Negative Breast Cancer in the Neoadjuvant/Adjuvant Setting (REaCT-TNBC)

Who this might be right for
Breast Cancer
Ottawa Hospital Research Institute 2
Testing effectiveness (Phase 2)Looking for participantsNCT07276880
What this trial is testing

Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer

Who this might be right for
Breast CancerTriple Negative Breast Cancer (TNBC)HER2-Negative Breast Carcinoma+1 more
UNC Lineberger Comprehensive Cancer Center 32
Testing effectiveness (Phase 2)Looking for participantsNCT07064018
What this trial is testing

Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies

Who this might be right for
Soft-tissue SarcomaTriple Negative Breast CancerNon-small Cell Lung Cancer+3 more
University of California, Irvine 67
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07217990
What this trial is testing

Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast CancerTriple Negative Breast Cancer
Ohio State University Comprehensive Cancer Center 84
Testing effectiveness (Phase 2)Ended earlyNCT05451849
What this trial is testing

A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer

Who this might be right for
MesotheliomaMesotheliomas PleuralMesothelioma, Malignant+14 more
TCR2 Therapeutics 14
Testing effectiveness (Phase 2)Study completedNCT01629615
What this trial is testing

A Trial of BKM120 (a PI3K Inhibitor) in Patients With Triple Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 50
Testing effectiveness (Phase 2)UnknownNCT01528826
What this trial is testing

Salvage Chemotherapy of Vinorelbine Plus Oxaliplatin in Metastatic Triple-negative Breast Cancer:a Prospective Trial

Who this might be right for
Breast Cancer
Fudan University 35
Testing effectiveness (Phase 2)Study completedNCT06604858
What this trial is testing

Neoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast Cancer

Who this might be right for
Breast CancerTriple Negative Breast Cancer
MedSIR 31
Testing effectiveness (Phase 2)Looking for participantsNCT04954599
What this trial is testing

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Maastricht University Medical Center 126
Testing effectiveness (Phase 2)Study completedNCT01997333
What this trial is testing

Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer

Who this might be right for
Metastatic gpNMB Over-expressing Triple Negative Breast Cancer
Celldex Therapeutics 327
Large-scale testing (Phase 3)Looking for participantsNCT04722978
What this trial is testing

Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Sun Yat-Sen University Cancer Center 228
Testing effectiveness (Phase 2)Study completedNCT03997968
What this trial is testing

CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors

Who this might be right for
MalignancyNon-hodgkin LymphomaMultiple Myeloma+12 more
Cyteir Therapeutics, Inc. 169
Testing effectiveness (Phase 2)Ended earlyNCT04191135
What this trial is testing

Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction With First-Line Chemotherapy Plus Pembrolizumab in Triple Negative Breast Cancer (TNBC) (MK-7339-009/KEYLYNK-009)

Who this might be right for
Triple Negative Breast Neoplasms
Merck Sharp & Dohme LLC 462
Testing effectiveness (Phase 2)Ended earlyNCT04442126
What this trial is testing

NM21-1480 in Adult Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorNon-small Cell Lung CancerColorectal Cancer+6 more
Numab Therapeutics AG 52
Large-scale testing (Phase 3)Not Yet RecruitingNCT07556848
What this trial is testing

9MW2821 Versus Chemotherapy in Participants With Previously Treated Locally Advanced or Metastatic Triple-Negative Breast Cancer

Who this might be right for
Locally Advanced or Metastatic Triple-negative Breast Cancer
Mabwell (Shanghai) Bioscience Co., Ltd. 356
Early research (Phase 1)UnknownNCT03151447
What this trial is testing

Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Metastatic Triple Negative Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Fudan University 18
Next Page